Primary hepatocellular carcinoma
Conditions
Interventions
PVE group :PVE treatment
LVD group :LVD treatment
Sponsors
The First Affiliated Hospital of USTC
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-75 years old, male and female; (2) Hepatocellular carcinoma (HCC) diagnosed by histopathology, immunohistochemistry or imaging examination, which is too large to be resected by one-stage operation; (3) There was no distant metastasis; (4) FLR was less than 20% in patients with normal liver function, less than 30% in patients with fatty liver and chemotherapy, and less than 40% in patients with compensatory cirrhosis; (5) Except for liver-related functions, other main organs function normally; (6) Subjects volunteered to join the study, signed informed consent, good compliance, with follow-up; (7) Researchers believe that patients can benefit.
Exclusion criteria
Exclusion criteria: (1) The subjects withdrew their consent; (2) Adverse reactions; (3) No treatment due to progress; (4) Death of patients; (5) Loss of follow-up; (6) Other.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased liver volume; | — |
Countries
China
Contacts
Public ContactLiu Lianxin
The First Affiliated Hospital of USTC
Outcome results
None listed